Clinical Trial of TQB2922 Injection (Subcutaneous Injection) in Patients With Advanced Cancers | MicrobiomeTrials← Back to trialsNCT07260708
Clinical Trial of TQB2922 Injection (Subcutaneous Injection) in Patients With Advanced Cancers
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2025-12-16Est. Completion: 2029-12
Enrollment target: 42 participants Locations- Peking University Shougang Hospital, Beijing, Beijing Municipality, China
- Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
- Henan Cancer Hospital, Zhengzhou, Henan, China
- The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
- Hunan Cancer Hospital, Changsha, Hunan, China
- Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China
- The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
- Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China
- Shandong Cancer Hospital, Jinan, Shandong, China
- Shanghai Pulmonary Hospital, Shanghai, Shanghai Municipality, China
- West China hospital, Sichuan University, Chengdu, Sichuan, China
- Chengdu Third People's Hospital, Chengdu, Sichuan, China
Other microbiome trials you might be interested in
Advanced Solid TumorMetastatic Solid Tumor
The purpose of this study is to describe the safety, tolerability and early signs of efficacy of the antibody-cytokine f…
Hamburg, GermanyEst. completion Dec 2026
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Locally Recurrent Head and Neck Squamous Cell CarcinomaLocally Recurrent Hypopharyngeal Squamous Cell CarcinomaLocally Recurrent Laryngeal Squamous Cell Carcinoma
Li Zhang, Doctor
Locally Recurrent Oral Cavity Squamous Cell Carcinoma
Locally Recurrent Oropharyngeal Squamous Cell Carcinoma
Stage II Laryngeal Cancer AJCC v8
Stage II Lip and Oral Cavity Cancer AJCC v8
Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage III Laryngeal Cancer AJCC v8
Stage III Lip and Oral Cavity Cancer AJCC v8
Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage IVA Laryngeal Cancer AJCC v8
Stage IVA Lip and Oral Cavity Cancer AJCC v8
Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage IVB Laryngeal Cancer AJCC v8
Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
This phase II trial tests the addition of chemotherapy, with carboplatin and paclitaxel, or chemo-immunotherapy, with ca…
Tucson, United StatesEst. completion Feb 1, 2033
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative NeoplasmAcute Myeloid Leukemia Post Cytotoxic TherapyAcute Myeloid Leukemia, Myelodysplasia-RelatedMyelodysplastic Syndrome
This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates the use of a screening tool and specific lab…
Birmingham, United StatesEst. completion May 15, 2029